General MedicationsINJECTIONGeneric
CEFPIRAMIDE SODIUM
CEFPIRAMIDE SODIUM
Standard Dose
EQ 10GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview CEFPIRAMIDE SODIUM is listed in Drugs@FDA under application 050633 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFPIRAMIDE SODIUM Form and strength INJECTABLE;INJECTION - EQ 10GM BASE/VIAL Sponsor WYETH AYERST Submission history Latest submission status date: 1991-08-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview CEFPIRAMIDE SODIUM is listed in Drugs@FDA under application 050633 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFPIRAMIDE SODIUM Form and strength INJECTABLE;INJECTION - EQ 10GM BASE/VIAL Sponsor WYETH AYERST Submission history Latest submission status date: 1991-08-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.